Satellos Bioscience MSLE
NASDAQ MSLE
$8.60 -0.21 (-2.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) EBITDA (2025 - 2026)

Updated

Satellos Bioscience's EBITDA was -$11.67 million in the quarter ended Jun 30, 2026, compared with -$5.58 million a year earlier.

Analysis

Satellos Bioscience (MSLE) EBITDA (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Satellos Bioscience's EBITDA was -$20.9 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was -$26.46 million.

  • In earlier years, EBITDA was -$20.38 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.10 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 8.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 5.09 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.30 Bn
10 Satellos Bioscience 136.19 Mn 136.19 Mn - -11.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.67 Mn
Mar 31, 2026 -9.73 Mn
Jun 30, 2025 -5.58 Mn
Mar 31, 2025 6.08 Mn
API Access

Satellos Bioscience EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=MSLE&period=max&api_key=YOUR_API_KEY